A Randomized Clinical Trial Using Fine Needle Aspiration For Evaluation of Hepatic Pharmacokinetics of MK-5172 in Participants With Chronic Hepatitis C.
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 10 Dec 2014
At a glance
- Drugs Grazoprevir (Primary) ; Peginterferon alfa-2b; Ribavirin
- Indications Hepatitis C
- Focus Pharmacokinetics
- Sponsors Merck Sharp & Dohme
- 23 May 2012 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 30 Mar 2012 Planned end date changed from 1 Sep 2012 to 1 Nov 2012 as reported by ClinicalTrials.gov.
- 30 Mar 2012 Planned initiation date changed from 1 Mar 2012 to 1 May 2012 as reported by ClinicalTrials.gov.